Research Article

TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients

Figure 2

Kaplan-Meier survival curves for grade III gliomas. The graph shows a shorter survival in patients with the TREM-1/TREM-2 () (test used: Log Rank; -axis: survival time in months; -axis: survival probability; 0: patients with TREM-1/TREM-2 (); 1: patients with TREM-1/TREM-2 ()).